Genocea Biosciences, Inc. 0A51.L Stock
Genocea Biosciences, Inc. Price Chart
Genocea Biosciences, Inc. 0A51.L Financial and Trading Overview
Genocea Biosciences, Inc. stock price | 0.0002 USD |
Previous Close | 0.0001 USD |
Open | 0 USD |
Bid | 0 USD x N/A |
Ask | 0 USD x N/A |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 0.02 USD |
Volume | 41.8K USD |
Avg. Volume | 2.79K USD |
Market Cap | N/A |
Beta (5Y Monthly) | 2.063732 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.533 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0A51.L Valuation Measures
Enterprise Value | -4646121 USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.00047393364 |
Enterprise Value/Revenue | -2.431 |
Enterprise Value/EBITDA | 0.083 |
Trading Information
Genocea Biosciences, Inc. Stock Price History
Beta (5Y Monthly) | 2.063732 |
52-Week Change | -99.53% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.02 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 0.008488889 USD |
200-Day Moving Average | 0.008488889 USD |
0A51.L Share Statistics
Avg. Volume (3 month) | 2.79K USD |
Avg. Daily Volume (10-Days) | 2.35K USD |
Shares Outstanding | N/A |
Float | 54.11M |
Short Ratio | N/A |
% Held by Insiders | 6.22% |
% Held by Institutions | 0.61% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | March 31, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -2958.87% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -57.59% |
Return on Equity (ttm) | -525.77% |
Income Statement
Revenue (ttm) | 1.91M USD |
Revenue Per Share (ttm) | 0.03 USD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 1.64M USD |
EBITDA | -55668000 USD |
Net Income Avi to Common (ttm) | -37191000 USD |
Diluted EPS (ttm) | -0.533 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 20.14M USD |
Total Cash Per Share (mrq) | 0.34 USD |
Total Debt (mrq) | 15.49M USD |
Total Debt/Equity (mrq) | 125.03 USD |
Current Ratio (mrq) | 1.354 |
Book Value Per Share (mrq) | 0.211 |
Cash Flow Statement
Operating Cash Flow (ttm) | -48186000 USD |
Levered Free Cash Flow (ttm) | -31454624 USD |
Profile of Genocea Biosciences, Inc.
Country | United Kingdom |
State | MA |
City | Cambridge |
Address | 100 Acorn Park Drive |
ZIP | 02140 |
Phone | 617 876 8191 |
Website | https://www.genocea.com |
Industry | |
Sector(s) | |
Full Time Employees | 74 |
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts. The plan was later approved as Chapter 11 liquidation on May 11, 2023.
Q&A For Genocea Biosciences, Inc. Stock
What is a current 0A51.L stock price?
Genocea Biosciences, Inc. 0A51.L stock price today per share is 0.0002 USD.
How to purchase Genocea Biosciences, Inc. stock?
You can buy 0A51.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genocea Biosciences, Inc.?
The stock symbol or ticker of Genocea Biosciences, Inc. is 0A51.L.
How many shares does Genocea Biosciences, Inc. have in circulation?
The max supply of Genocea Biosciences, Inc. shares is 0.
What is Genocea Biosciences, Inc. Price to Earnings Ratio (PE Ratio)?
Genocea Biosciences, Inc. PE Ratio is now.
What was Genocea Biosciences, Inc. earnings per share over the trailing 12 months (TTM)?
Genocea Biosciences, Inc. EPS is -0.533 USD over the trailing 12 months.